Advances in Malignant Lymphoma


Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application
June 22-26, 2018
Boston Marriott Copley Place
Boston, Massachusetts

View meeting website.

Scientific Committee Chair
Ari M. Melnick
, Weill Cornell Medical College, New York, New York

Scientific Committee Cochairs
Francesco Bertoni
, Institute of Oncology Research, Bellinzona, Switzerland
Renier J. Brentjens, Memorial Sloan Kettering Cancer Center, New York, New York
Bertrand Nadel, Centre d'Immunologie de Marseille-Luminy, Marseille, France
Lisa G. Roth, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York
Louis M. Staudt, National Cancer Institute, Bethesda, Maryland
Christian Steidl, BC Cancer Agency Vancouver Center, Vancouver, British Columbia, Canada
Karine Tarte, Pontchaillou Hospital, Rennesiedex, France
Thomas E. Witzig, Mayo Clinic College of Medicine, Rochester, Minnesota
Wei-Li Zhao, Ruijin Hospital, Shanghai Institute of Hematology, Shanghai, China

Scientific Advisory Committee
Riccardo Dalla-Favera
, Columbia University Institute for Cancer Genetics, New York, New York
Jude Fitzgibbon, Barts Cancer Institute, London, England
Christopher R. Flowers, Emory University Winship Cancer Institute, Atlanta, Georgia
Lee M. Greenberger, The Leukemia & Lymphoma Society, Rye Brook, New York
Ricky W. Johnstone, Peter MacCallum Cancer Center, Melbourne, Australia
Ronald Levy, Stanford University, Stanford, California
Tak W. Mak, Campbell Family Institute for Breast Cancer Research, Toronto, Canada
Kristy L. Richards, Cornell University, Ithaca, New York
David M. Weinstock, Dana-Farber Cancer Institute, Boston, Massachusetts
Anas Younes, Memorial Sloan Kettering Cancer Center, New York, New York

Start Date: Friday, June 22, 2018
End Date: Tuesday, June 26, 2018
Address: Boston Marriott Copley Place
Boston, MA

You must log on
or create a new account
before continuing through the checkout process.

Find an existing account.